| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |